This project aims to evaluate the efficacy of (1) single-dose Ivermectin in reducing viral load in COVID-19 patients, (2) Ivermectin in time with clinical improvement, the percentage of patients progressing to severe disease, and frequency of adverse
Section: Medical Sciences (Research Project)
Related:
A randomized
A randomized controlled trial of single-dose oral ivermectin in patients with Covid-19 infection
Research Project › Medical Sciences
A phase
A phase II B open label randomised controlled trial to evaluate the efficacy and safety of Ivermectin in reducing viral loads in patients with hematological disorders who are admitted with COVID-19 infection (ICE study)
Research Project › Medical Sciences
A phase
A phase Iib openlabel randomized controlled trial to evaluate the efficacy & safety of Ivermectin in reducing viral loads in patients with hematological disorders who are admitted with Covid-19 infection (Ice study)
Research Project › Medical Sciences
DEVELOPMENT OF
DEVELOPMENT OF INHALABLE SPRAY-DRIED LYOTROPIC LIQUID CRYSTALS OF AMPHOTERICIN B AND N-ACETYL CYSTEINE FOR INVASIVE PULMONARY MUCORMYCOSIS
Research Project › Life Sciences & Biotechnology